Abstract:Introduction/Background: Deep neural networks have shown great promise in advancing drug discovery and precision medicine. By leveraging large amounts of complex biomedical and chemical data, deep learning approaches can identify novel targets, predict drug-target and drug-drug interactions, generate new molecular structures, and assist in personalized treatment selection and development. However, fully utilizing deep learning techniques for optimization across the drug development pipeline remains an ongoing challenge. Materials and Methods: A comprehensive literature review was conducted using major bibliographic databases including PubMed, Web of Science, and Scopus. Search terms included combinations of "deep learning", "drug discovery", "precision medicine", "biomedical data", and "neural networks". Over 200 papers published between 2010-2023 related to deep learning applications in pharmacology and genomics were identified and reviewed. Results: Deep learning has been widely applied at various stages of the drug discovery process including target identification/prioritization, lead generation/optimization, and prediction of molecular properties. Convolutional neural networks are commonly used for the representation and classification of biological sequence and image data for tasks such as gene expression analysis and pathogen detection from microscopy images. Graph neural networks effectively model compound structures and interactome networks to predict molecular bindings and disease associations. Multi-modal neural networks integrate diverse data types for personalized treatment response prediction and biomarker discovery. Challenges remain around data and model interpretation, generalization to new targets/diseases, and integration across domains. Discussion: While deep learning has shown promise, rigorous benchmarking and validation on real-world clinical endpoints are still needed to establish usefulness in decision-making. Data and model transparency must be improved to enable scientific insights. Privacy and security risks accompanying "real world" biomedical big data will require ethical practices. Standardization and sharing of resources/protocols could accelerate progress by enabling comparison of techniques. Combining deep learning with other AI paradigms like causal inference may further improve utility in drug discovery and precision healthcare. Conclusion: Deep neural networks demonstrate potential for optimizing drug development and precision medicine applications. Continued advancement relies on addressing challenges around data, models, validation, and ethics. Multi-disciplinary collaborations integrating machine learning, molecular biology, medicine, and other domains are needed to fully realize benefits to patients.

A compact review of progress and prospects of deep learning in drug discovery

Advances in Deep Learning Assisted Drug Discovery Methods: A Self-review

A Review Of Deep Learning In Computer-Aided Drug Design

A Comprehensive Review on Machine Learning and Deep Learning Methods in Drug Discovery

Deep Learning in Drug Discovery: Current Landscape and Future Prospects

Recent Progress of Deep Learning in Drug Discovery

Application of Deep Learning Neural Networks in Computer-aided Drug Discovery: A Review

Evaluating deep neural networks in optimizing drug discovery and precision medicine: A review

Deep learning for low-data drug discovery: hurdles and opportunities

Deep learning tools for advancing drug discovery and development

Implementation of Deep Learning in Drug Design

The rise of deep learning in drug discovery

Correction To: Deep Learning for Drug Design: an Artificial Intelligence Paradigm for Drug Discovery in the Big Data Era

Deep Learning Methods for Small Molecule Drug Discovery: A Survey

Recent applications of deep learning and machine intelligence on in silico drug discovery: methods, tools and databases

The changing scenario of drug discovery using AI to deep learning: Recent advancement, success stories, collaborations, and challenges

Deep Learning in Drug Discovery and Medicine; Scratching the Surface

Deep Learning in Virtual Screening: Recent Applications and Developments

A comprehensive review of the recent advances on predicting drug-target affinity based on deep learning

Artificial intelligence in drug discovery: recent advances and future perspectives

Application advances of deep learning methods for de novo drug design and molecular dynamics simulation